Krisko, Tibor

Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease

McMahan, R. H., Wang, X. X., Cheng, L. L., Krisko, T., Smith, M., El Kasmi, K., Pruzanski, M., Adorini, L., Golden-Mason, L., Levi, M., et al. (2013) · Journal of Biological Chemistry

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 225

Gastrointestinal and hepatic manifestations of 2019 novel coronavirus disease in a large cohort of infected patients from New York: Clinical implications

Hajifathalian, K., Krisko, T., Mehta, A., Kumar, S., Schwartz, R., Fortune, B., Sharaiha, R. Z., Kaplan, A., Gonzalez, S., Skaf, D., et al. (2020) · Gastroenterology

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19

Cited by 150

Mo1918: Gastrointestinal Symptoms from Semaglutide Are Common in Real-World Clinical Practice, Though Medication Discontinuation Rates Are Similar among Patients with or without Prior Digestive Complaints

Cornet, N., Rogers, L., Magahis, P. T., Sharaiha, R. Z., Yeung, M., Krisko, T., Buckholz, A., Kumar, S., & Newberry, C. (2023) · Gastroenterology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 1